02
2023/06
Norroy’s First-in-Human Clinical Results for First-Generation Renal Cancer Radiopharmaceutical
目的 碳酸酐酶IX(CAIX)在透明細胞腎細胞癌(ccRCC)高度表達。本研究的目的是評估一種小分子的CAIX靶向PET示蹤劑68Ga-NY104(NYM005),在ccRCC的腫瘤模型和確診或疑似的ccRCC患者中的應用。 ...
MORE >>
25
2023/05
Sunmao Medical first published the M1 Poster at iSRS 2023
The 25th International Symposium on Radiopharmaceutical Sciences was held in May 2023 in Hawaii. Abstract papers of Mortenon M1 were prese...
MORE >>
13
2023/05
Norroy completed the A-round financing signing ceremony and continued cooperation with Xinghua Dingli.
Recently, Norroy Bioscience Co., Ltd. A-round of financing signing ceremony was held in Wuxi, Xinghua Dingli founder Mr. Wu Yuding and CEO of N...
MORE >>
13
2023/05
Radioisotope workplace of Norroy bioscience officially put into use
Recently, the opening ceremony of the Radioisotope laboratory of Norroy bioscience Co., Ltd. was officially held in Wuxi. Mr. Wu Yuding, fo...
MORE >>
Address: No.35-208, Changjiangnan Road, XinWu District, Wuxi, China
Mail address: bd@norroybioscience.com
Website: www.adm5.cn